Filing Details
- Accession Number:
- 0001209191-20-058235
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-13 12:17:24
- Reporting Period:
- 2020-11-11
- Accepted Time:
- 2020-11-13 12:17:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1175505 | Five Prime Therapeutics Inc. | FPRX | Pharmaceutical Preparations (2834) | 260038620 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238325 | R William Ringo | 111 Oyster Point Boulevard South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-11 | 52,959 | $2.22 | 62,959 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-11 | 52,959 | $22.50 | 10,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-11 | 26,000 | $2.80 | 36,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-11 | 26,000 | $22.50 | 10,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-11-11 | 52,959 | $0.00 | 52,959 | $2.22 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-11-11 | 26,000 | $0.00 | 26,000 | $2.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2030-03-18 | No | 4 | M | Direct | |
| 52,408 | 2030-04-18 | No | 4 | M | Direct |
Footnotes
- The exercises and sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- This option vested in its entirety on April 19, 2020.
- This option vested in its entirety on May 19, 2020.
Billionaire Hedge Funds
